IMBdx
IMBdx
Share · KR7461030009 (XKOS)
Overview
No Price
Closing Price XKOS 03.02.2026: 9.270,00 KRW
03.02.2026 06:30
Current Prices from IMBdx
ExchangeTickerCurrencyLast TradePriceDaily Change
XKOS: KOSDAQ
KOSDAQ
461030.KQ
KRW
03.02.2026 06:30
9.270,00 KRW
270,00 KRW
+3,00 %
Share Float & Liquidity
Free Float 36,18 %
Shares Float 5,07 M
Shares Outstanding 14,02 M
Company Profile for IMBdx Share
IMBdx, Inc. engages in the development of liquid biopsy tests for cancer diagnosis. It focuses on the following business areas: diagnosis and treatment of advanced cancer, early detection of recurrence after surgery, and early cancer diagnosis. Its products include AlphaLiquid, CancerDetect, and CancerFind. The company was founded by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018 and is headquartered in Seoul, South Korea.
AI Analysis of IMBdx
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of IMBdx
No AI threads available for this company yet.

Company Data

Name IMBdx
Company IMBdx
Website http://www.imbdx.com
Primary Exchange XKOS KOSDAQ
ISIN KR7461030009
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Tae-You Kim
Market Capitalization 126 Mrd.
Country South Korea
Currency KRW
Employees 0,1 T
Address BYC Highcity Bldg A, Seoul
IPO Date 2024-04-01

Ticker Symbols

Name Symbol
KOSDAQ 461030.KQ
More Shares
Investors who hold IMBdx also have the following shares in their portfolio:
AAREAL BANK SUB.MTN 14/22
AAREAL BANK SUB.MTN 14/22 Bond
AEW UK REIT PLC - ORD GBP0.01
AEW UK REIT PLC - ORD GBP0.01 Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026